Increased expression of EGFR which is induced by CGF (cancer upregulated gene 2) has been shown to induce doxorubicin resistance through the Stat1-HDAC4 signal in lung cancer cells (Kaowinn et al., 2017[15]). This evidence concerns the gene EGFR and lung cancer.